Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
3(43%)
Results Posted
0%(0 trials)
Terminated
1(14%)

Phase Distribution

Ph early_phase_1
1
14%
Ph not_applicable
5
71%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

3

trials recruiting

Total Trials

7

all time

Status Distribution
Active(4)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Recruiting2
Terminated1
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
3
Success Rate
66.7%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (16.7%)
N/A5 (83.3%)

Trials by Status

terminated114%
completed229%
active_not_recruiting114%
not_yet_recruiting114%
recruiting229%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DEVICE
Total Trials
7